TY  - GEN
AU  - Fiskus,Warren
AU  - Cai,Tianyu
AU  - DiNardo,Courtney D
AU  - Kornblau,Steven M
AU  - Borthakur,Gautam
AU  - Kadia,Tapan M
AU  - Pemmaraju,Naveen
AU  - Bose,Prithviraj
AU  - Masarova,Lucia
AU  - Rajapakshe,Kimal
AU  - Perera,Dimuthu
AU  - Coarfa,Cristian
AU  - Mill,Christopher P
AU  - Saenz,Dyana T
AU  - Saenz,David N
AU  - Sun,Baohua
AU  - Khoury,Joseph D
AU  - Shen,Yu
AU  - Konopleva,Marina
AU  - Bhalla,Kapil N
TI  - Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells
SN  - 2044-5385
PY  - 2019///1230
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Binding Sites
KW  - Biomarkers, Tumor
KW  - Cell Line, Tumor
KW  - Disease Models, Animal
KW  - Drug Synergism
KW  - Female
KW  - Humans
KW  - Indoles
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Myeloid Cell Leukemia Sequence 1 Protein
KW  - antagonists & inhibitors
KW  - Neoplastic Stem Cells
KW  - drug effects
KW  - Protein Binding
KW  - Protein Kinase Inhibitors
KW  - Proteins
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Pyridones
KW  - Sulfonamides
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41408-018-0165-5
ER  -